Prognostic Impact of <i>IGF2BP3</i> Expression in Patients with Surgically Resected Lung Adenocarcinoma
Wei Guo(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College), Huan Wan(Chinese Academy of Medical Sciences & Peking Union Medical College), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Qilin Huai(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 50
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Cancer registration in China and its role in cancer prevention and control
|The Lancet Oncology|2020|501
Participation and yield of a population-based colorectal cancer screening programme in China
|Gut|2018|409
Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN
|The Lancet. Gastroenterology & hepatology|2024|248